Gufic Biosciences Limited (GUFICBIO)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
240.5
-3.25(-1.33%)

Gufic Biosciences Limited engages in the research, development, manufacture, and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, aesthaderum, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to countries across Asia, Africa, Latin American, and GCC markets. The company was founded in 1970 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

249.15

TODAY'S LOW

233.55

52 WEEK HIGH

290

52 WEEK LOW

171.1

Major Holders

% of Shares Held by
All Insider

78.32%

% of Shares Held by
Institutions

2.52%

% of Float Held by
Institutions

11.64%

Number of Institutions
Holding Shares

5

Company Overview

MARKET CAP

2331.51 Cr.

ETERPRISE VALUE

2326.33 Cr.

NO. OF SHARES

9.69 Cr.

BOOK VALUE

23.573

DIV. YIELD

0.1%

DEBT

35.31 Cr.

GROSS PROFIT

231.18 Cr.

CASH

72.96 Cr.

REVENUE

748.89 Cr.

REVENUE/SHARE

77.37

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments0000
Change To Liabilities90.19 Lakhs27.42 Cr.1.64 Cr.24.48 Cr.
Total cashflows from Investing Activities-8.50 Cr.-42.53 Cr.-12.99 Cr.-8.83 Cr.
Net Borrowings-64.83 Cr.10.01 Cr.18.06 Cr.22.95 Cr.
Total Cash from Financing Activities-78.61 Cr.-4.20 Cr.7.70 Cr.14.40 Cr.
Other Liabilities0000
Total Assets0000
Net Income44.23 Cr.22.68 Cr.21.94 Cr.16.47 Cr.
Change in Cash1.94 Cr.36.49 Lakhs-7.76 Lakhs74.62 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities89.06 Cr.47.10 Cr.5.20 Cr.-4.81 Cr.
Depreciation16.27 Cr.13.82 Cr.4.59 Cr.4.37 Cr.
Other Cashflows from Investing Activities5.70 Cr.-2.69 Cr.8.45 Lakhs-59.19 Lakhs
Dividends Paid-36.29 Lakhs-48.75 Lakhs-38.75 Lakhs-38.76 Lakhs
Change to Inventory28.05 Cr.-8.22 Cr.-8.36 Lakhs-30.78 Cr.
Change to Account Receivables-18.99 Cr.-16.71 Cr.-35.08 Cr.-24.10 Cr.
Other Cashflows from Financing Activities-13.41 Cr.-13.73 Cr.-9.96 Cr.-8.16 Cr.
Change to Net Income18.57 Cr.8.07 Cr.12.14 Cr.4.70 Cr.
Capital Expenditures-14.21 Cr.-39.84 Cr.-13.08 Cr.-8.10 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax57.71 Cr.30.12 Cr.35.34 Cr.29.95 Cr.
Minority InterestNoneNoneNoneNone
Net Income67.65 Cr.38.53 Cr.41.34 Cr.34.39 Cr.
Selling General Administrative69.11 Cr.63.73 Cr.52.52 Cr.47.92 Cr.
Gross Profit231.18 Cr.193.79 Cr.168.55 Cr.158.33 Cr.
Ebit67.65 Cr.38.53 Cr.41.34 Cr.34.39 Cr.
Operating Income67.65 Cr.38.53 Cr.41.34 Cr.34.39 Cr.
Other Operating Expenses78.12 Cr.77.66 Cr.70.04 Cr.71.61 Cr.
Interest Expense-11.76 Cr.-12.67 Cr.-10.02 Cr.-8.65 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense13.47 Cr.7.43 Cr.13.40 Cr.13.47 Cr.
Total Revenue487.69 Cr.378.83 Cr.350.76 Cr.305.58 Cr.
Total Operating Expenses420.04 Cr.340.29 Cr.309.42 Cr.271.19 Cr.
Cost of Revenue256.51 Cr.185.03 Cr.182.21 Cr.147.24 Cr.
Total Other Income Expense Net-9.94 Cr.-8.41 Cr.-5.99 Cr.-4.43 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.44.23 Cr.22.68 Cr.21.94 Cr.16.47 Cr.
Net Income Applicable to Common Shares44.23 Cr.22.68 Cr.21.94 Cr.16.47 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets44.51 Lakhs53.60 Lakhs34.40 Lakhs43.73 Lakhs
Capital Surplus026.25 Lakhs16.45 Lakhs79.73 Lakhs
Total Liabilities218.62 Cr.278.19 Cr.204.19 Cr.183.89 Cr.
Stock Holder Equity173.43 Cr.129.32 Cr.75.34 Cr.54.13 Cr.
Minority Interest0000
Other Liabilities8.14 Cr.7.30 Cr.9.55 Cr.7.24 Cr.
Total Assets392.06 Cr.407.51 Cr.279.53 Cr.238.03 Cr.
Common Stock9.69 Cr.9.69 Cr.7.78 Cr.7.78 Cr.
Retained Earnings95.03 Cr.50.92 Cr.67.32 Cr.45.43 Cr.
Other Liabilities16.71 Cr.12.67 Cr.6.53 Cr.7.02 Cr.
Good Will02.10 Lakhs2.24 Lakhs2.80 Lakhs
Treasury Stock68.71 Cr.68.43 Cr.7.14 Lakhs12.50 Lakhs
Other Assets18.10 Cr.21.01 Cr.12.94 Cr.14.92 Cr.
Cash6.20 Cr.4.26 Cr.3.66 Cr.3.73 Cr.
Current Liabilities163.66 Cr.239.77 Cr.186.34 Cr.168.54 Cr.
Long Term Asset Charges063.60 Lakhs68.96 Lakhs2.80 Cr.
Short Long Term Debt3.59 Cr.4.09 Cr.1.74 Cr.2.13 Cr.
Other Stockholder Equity68.71 Cr.68.43 Cr.7.14 Lakhs12.50 Lakhs
Property Plant Equipment112.92 Cr.112.63 Cr.33.70 Cr.24.43 Cr.
Total Cur. Assets260.58 Cr.273.30 Cr.232.51 Cr.198.20 Cr.
Long Term Investments75 k75 k50 k50 k
Net Tangible Assets172.99 Cr.128.76 Cr.74.98 Cr.53.67 Cr.
Short Term Investments0000
Net Receivables124.75 Cr.107.35 Cr.103.91 Cr.81.02 Cr.
Long Term Debt35.42 Cr.19.54 Cr.11.31 Cr.8.28 Cr.
Inventory94.40 Cr.122.46 Cr.94.28 Cr.94.20 Cr.
Accounts Payable113.02 Cr.117.06 Cr.77.80 Cr.75.97 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account